Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+Breast Cancer With Brain Metastases: NRG Oncology - KROG/ RTOG 1119 Phase 2 Randomized Trial Article

Kim, In Ah, Winter, Kathryn A, Sperduto, Paul W et al. (2024). Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+Breast Cancer With Brain Metastases: NRG Oncology - KROG/ RTOG 1119 Phase 2 Randomized Trial . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 118(5), 1391-1401. 10.1016/j.ijrobp.2023.07.019

International Collaboration

cited authors

  • Kim, In Ah; Winter, Kathryn A; Sperduto, Paul W; De Los Santos, Jennifer F; Peereboom, David M; Ogunleye, Tomi; Boulter, Daniel; Fritz, Joel M; Cho, Kwan Ho; Shin, Kyung Hwan; Zoberi, Imran; Choi, Serah; Palmer, Joshua D; Liem, Ben; Kim, Yong Bae; Anderson, Bethany M; Thakrar, Anupama W; Muanza, Thierry M; Kim, Michelle M; Choi, Doo Ho; Mehta, Minesh P; White, Julia R

sustainable development goals

authors

publication date

  • April 1, 2024

published in

keywords

  • 2-POSITIVE BREAST-CANCER
  • II TRIAL
  • Life Sciences & Biomedicine
  • NERATINIB
  • Oncology
  • PLUS CAPECITABINE
  • RADIOTHERAPY
  • Radiology, Nuclear Medicine & Medical Imaging
  • SURVIVAL
  • Science & Technology
  • TBCRC 022
  • TRASTUZUMAB
  • WOMEN

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 1391

end page

  • 1401

volume

  • 118

issue

  • 5